SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Nebraska
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
Beth Israel Deaconess Medical Center
University of California, San Francisco
Barbara Ann Karmanos Cancer Institute
Mayo Clinic